Skip to main content
SpringerLink
Log in

Pharmacokinetics of sulfamethoxazole - trimethoprim combination during chronic peritoneal dialysis: Effect of peritonitis

  • Originals
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

Summary

The pharmacokinetics of the fixed combination trimethoprim sulfamethoxazole (TMP — SMZ), including peritoneal transfer, has been studied in patients with end-stage renal disease treated by peritoneal dialysis, intermittent in 18 cases and continuous ambulatory dialysis in 6 cases. After a single oral dose of TMP 4mg and SMZ 20mg per kg, peak serum levels of approximately 2.0 µg/ml TMP and 28 µg/ml SMZ were achieved at 4hours for TMP, and at 6 hours for SMZ. The protein binding of TMP was 34.7±1.1% and its distribution volume was 2.2±0.51/kg. Total plasma clearance of TMP was 66.2±11.5ml/min, peritoneal dialysance was 5.1±0.5ml/min, and renal clearance was negligible. The protein binding of SMZ was 48.0 ±1.4% and the distribution volume was 0.55±0.071/kg. Total plasma clearance of SMZ was 26.2±5.7ml/min, peritoneal dialysance was 1.2±0.2ml/min, and renal clearance was negligible. The half lives of TMP and SMZ were 23.7±4.0h and 18.1±3.5h, respectively. The peritoneal dialysance both of TMP and SMZ after oral administration was very low. In contrast the absorption after intra-peritoneal administration is high. Peritoneal absorption was increased during peritonitis. In patients with peritonitis, the intra-peritoneal administration of TMP-SMZ resulted in an immediate high local concentration, and a serum concentration of both drugs in the therapeutic range within 6 to 12h.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Tenckhoff H (1974) Chronic peritoneal dialysis manual. University of Washington, Seattle

    Google Scholar 

  2. Popovich RP, Moncrief JW, Nolph KD, Ghods AJ, Twardowski ZJ, Pyle WK (1978) Continuous ambulatory peritoneal dialysis. Ann Intern Med 88: 449–456

    Google Scholar 

  3. Legrain M (ed) (1979) Continuous ambulatory peritoneal dialysis: First international Symposium, Paris, Excerpta Medica, Amsterdam

  4. Moncrief, JW (ed) (1979) Continuous ambulatory peritoneal dialysis. Second International Symposium, Austin Excerpta Medica, Amsterdam

    Google Scholar 

  5. Rubin J, Rogers WA, Taylor HM, Everett ED, Prowant BF, Fruto LV, Nolph KD (1980) Peritonitis during continuous ambulatory peritoneal dialysis. Ann Intern Med 92: 7–13

    Google Scholar 

  6. Oreopoulos DG, Robson M, Izatt S, Clayton S, de Veber GA (1978) A simple and safe technique for continuous ambulatory peritoneal dialysis (CAPD). Trans Am Soc Artif Intern Organs 24: 484–489

    Google Scholar 

  7. Renaux C, Certain B, Mollet M, Rottembourg J (1980) La dialyse péritonéale continue ambulatoire. I, Le matériel et la technique. Nouv Presse Med 42: 3155–3158

    Google Scholar 

  8. Schwartz DE, Koechlin BA, Weinfeld RE (1969) Spectrofluorometric method for the determination of trimethoprim in body fluids. Chemotherapy 14: 22–29

    Google Scholar 

  9. Bratton AC, Marshall EK (1939) A new coupling component for sulfonamide determination. J Biol Chem 198: 537–541

    Google Scholar 

  10. Rieder (1972) Quantitative determination of bacteriostatically active fraction of sulfonamides and the sum of their inactive metabolites in the body fluids. Chemotherapy 17: 1–21

    Google Scholar 

  11. Brumfitt W, Hamilton-Miller JMT, Kosmidis J (1973) Trimethoprim Sulfamethoxazole: The present position. J Infect Dis 128: 778–791

    Google Scholar 

  12. Rieder J, Schwartz DE, Fernex M, Bergan I, Brodwall EK, Blumberg A, Cottier P, Scheitlin W (1974) Pharmacokinetics of the antibacterial combination sulfamethoxazole plus trimethoprim in patients with normal or impaired kidney function. Antibiot Chemother 18: 148–198

    Google Scholar 

  13. Gibson TP, Matusik E, Nelson LD, Briggs WA (1976) Artificial kidney and clearance calculations. Clin Pharmacol Ther 20: 720–726

    Google Scholar 

  14. Baethke R, Golde G, Gahl G (1972) Sulfamethoxazole — Trimethoprim: pharmacokinetic studies in patients with chronic renal failure. Eur J Clin Pharmacol 4: 233–240

    Google Scholar 

  15. Bergan T, Brodwall EK (1972) Kidney transport in man of sulfamethoxazole and trimethoprim. Chemotherapy 17: 320–333

    Google Scholar 

  16. Craig WA, Kunin CM (1973) Trimethoprim-Sulfamethoxazole: Pharmacodynamic effects of urinary pH and impaired renal function. Ann Intern Med 78: 491–497

    Google Scholar 

  17. Reeves DS, Wilkinson PJ (1979) The pharmacokinetic of trimethoprim and trimethoprim-sulfonamide combination including penetration in body tissues. Infection 7: S330-S341

    Google Scholar 

  18. Vree TB, Hekster YA, Baars AM, Dansma JE, van der Kleijn E (1978) Pharmacokinetics of sulfamethoxazole in Man. Clin Pharmacokinet 3: 319–329

    Google Scholar 

  19. Tasker PRW, Mac Gregor GA, de Wardener HE (1975) Use of co-trimoxazole in chronic renal failure. Lancet 1: 1216–1218

    Google Scholar 

  20. Fabre J, Balant L (1976) Renal failure, drug pharmacokinetic and drug action. Clin. Pharmacokinet 1: 99–120

    Google Scholar 

  21. Patel RB, Welling PG (1980) Clinical Pharmacokinetics of co-trimoxazole (trimethoprim-sulphamethoxazole). Clin. Pharmacokinet 5: 405–423

    Google Scholar 

  22. Rubin RH, Schwartz MN (1980) Trimethoprim-Sulfamethoxazole. N Engl J Med 303: 426–432

    Google Scholar 

  23. Anton AM, Corey WT (1971) Plasma protein binding of sulfonamides in anephric patients. Fed Proc 30: 629–634

    Google Scholar 

  24. Gugler R, Azarnoff DL (1976) Drug protein binding and the nephrotic syndrome. Clin Pharmacokinet 1: 25–35

    Google Scholar 

  25. Koch Weser J, Sellers AM (1976) Binding of drug to serum albumin. N Engl J Med 294: 526–530

    Google Scholar 

  26. Reidenberg MM (1970) The binding of drugs to plasma proteins and the interpretation of measurements of plasma concentrations of drugs in patients with poor renal function. Am J Med 62: 466–470

    Google Scholar 

  27. Welling PG, Craig WA, Amidon GL, Kunin CM (1973) Pharmacokinetics of trimethoprim and sulfamethoxazole in normal subjects and in patients with renal failure. J Infect Dis 128: 556–566

    Google Scholar 

  28. Golper TA (1979) Drug and peritoneal dialysis. Dialysis Transplant 8: 41–44

    Google Scholar 

  29. Hoppe Seyler G, Schollmeyer P, Grandpierre B, Löffler HD (1975) The relationship between sulfamethoxazole and trimethoprim pharmacokinetics and disturbed excretion in the functionally anephric patients undergoing home and peritoneal dialysis. Proc. 6th Int. Congress of Pharmacology, Helsinki. abst 492: 192

  30. Singlas E, Rottembourg J, de Martin A, Colin JN, Legrain M (1981) Pharmacokinetics of Co-trimoxazole using the peritoneal route. Consequence for the treatment of peritonitis in patients maintained on peritoneal dialysis. In: Moncrief JM (ed) Continuous ambulatory peritoneal dialysis. Int. Symposium II. Austin Excerpta Medica, Amsterdam

    Google Scholar 

  31. Kaplan SA, Weinfeld RE, Abruzzo CW, Macfaden K, Jack ML, Weissman L (1973) Pharmacokinetic profil of trimethoprim-sulfamethoxazole in man. J Infect Dis 128: 547–555

    Google Scholar 

  32. Rieder J (1973) Metabolism and techniques for assay of trimethoprim and sulfamethoxazole. J Infect Dis 128: 567–673

    Google Scholar 

  33. Schwartz DE, Vetter W, Englert G (1970) Trimethoprim metabolites in rat, dog and man: qualitative and quantitative studies. Arzneim Forsch 20: 1867–1871

    Google Scholar 

  34. Bohni E (1969) Vergleichende Untersuchungen mit der Kombination Trimethoprim/Sulfamethoxazol in vitro und in vivo. Chemotherapy 14: 1–21

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Departments of Clinical Pharmacology and Nephrology, Groupe Hospitalier Pitié-Salpétrière, Paris, France

    E. Singlas, J. N. Colin, J. Rottembourg, J. P. Meessen, A. de Martin, M. Legrain & P. Simon

Authors
  1. E. Singlas
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. J. N. Colin
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. J. Rottembourg
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. J. P. Meessen
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. A. de Martin
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. M. Legrain
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. P. Simon
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Singlas, E., Colin, J.N., Rottembourg, J. et al. Pharmacokinetics of sulfamethoxazole - trimethoprim combination during chronic peritoneal dialysis: Effect of peritonitis. Eur J Clin Pharmacol 21, 409–415 (1982). https://doi.org/10.1007/BF00542328

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00542328

Key words

Search

Navigation